Trial
NCT03613259
Fluorothymidine F-18 PET in Diagnosing Patients With Intermediate or High Grade Soft Tissue Sarcoma
Early Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
OHSU Knight Cancer Institute
Collaborators
National Cancer Institute (NCI)
Condition
Stage II Adult Soft Tissue Sarcoma
Intervention
Fluorothymidine F-18
Why stopped
Funding expired
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-06-09